Pfizer Inc (PFE)

$27.83 -0.41 (-1.45%)
Market Cap 155.32B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.81
Forward PE 9.03
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 20,329,260
Avg Vol 44,610,465
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 92%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
ResearchTrends09
ResearchTrends09 Aug. 20 at 6:32 PM
$PFE I want your shareholders to read this
2 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 20 at 5:54 PM
$PFE like it better than a bond or what?
0 · Reply
Cash_loot
Cash_loot Aug. 20 at 5:40 PM
$PFE Close eye on this one for a possible 30 run. Need a touch more data to determine if jumping in
0 · Reply
Maneee
Maneee Aug. 20 at 5:23 PM
$PFE I am bullish because the latest earnings report (Q2 2026, released August 4) was genuinely strong, particularly relative to expectations. The guidance was also improved. Pfizer raised the bottom end of 2026 revenue guidance by $1 billion. That's a positive signal because Pfizer is essentially saying its non-COVID business is performing better than previously anticipated. Pfizer is demonstrating that its underlying pharmaceutical business can grow even while COVID revenue continues disappearing.
0 · Reply
PredictionFLO1
PredictionFLO1 Aug. 20 at 5:19 PM
$PFE options flow lesson: volume and open interest answer different questions. Volume counts contracts traded during the session. Open interest is the standing balance from the prior settle. The two should not be treated as interchangeable. The alert snapshot shows $1.2M in the Oct 16 $28 calls. Volume was 0.5x standing open interest at capture. Intraday volume does not establish whether a position was opened or held; the next settled open interest is the check.
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 20 at 4:52 PM
$PFE We need some news to blow passed the negligible resistance for good. Maybe we have a cancer vaccine PR up our sleeve. Monday press release? Either way, $28 has to hold. (div adjusted major resistance.)
0 · Reply
CapitalMonk
CapitalMonk Aug. 20 at 4:44 PM
$PFE Price: $28.03 (-0.74%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.78% RSI: 80.6 | Momentum: Moderate Volume: -63.2% vs avg Volatility: 1.34% Support: $24.44 | Resistance: $28.44 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Bobfree
Bobfree Aug. 20 at 4:34 PM
$MRNA $PFE thanks, I feel a little better now that I'm making less on moderna
0 · Reply
Maneee
Maneee Aug. 20 at 4:12 PM
$PFE well, with the whole market red, its quickly returning to green today itself. what does it tell you? (its only gonna climb up now).
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 20 at 3:50 PM
$PFE what’s odd is that it’s on low volume lol
1 · Reply
Latest News on PFE
Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

2026-08-19T14:35:12.000Z - 1 day ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 4 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 6 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 6 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 6 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 6 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

2026-08-14T13:47:35.000Z - 6 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 6 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-07T11:40:49.000Z - 13 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 14 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 16 days ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 16 days ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 16 days ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 16 days ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 16 days ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 16 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 16 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 16 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 16 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 21 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 21 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 21 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 4 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 4 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 4 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 5 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 7 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

ResearchTrends09
ResearchTrends09 Aug. 20 at 6:32 PM
$PFE I want your shareholders to read this
2 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 20 at 5:54 PM
$PFE like it better than a bond or what?
0 · Reply
Cash_loot
Cash_loot Aug. 20 at 5:40 PM
$PFE Close eye on this one for a possible 30 run. Need a touch more data to determine if jumping in
0 · Reply
Maneee
Maneee Aug. 20 at 5:23 PM
$PFE I am bullish because the latest earnings report (Q2 2026, released August 4) was genuinely strong, particularly relative to expectations. The guidance was also improved. Pfizer raised the bottom end of 2026 revenue guidance by $1 billion. That's a positive signal because Pfizer is essentially saying its non-COVID business is performing better than previously anticipated. Pfizer is demonstrating that its underlying pharmaceutical business can grow even while COVID revenue continues disappearing.
0 · Reply
PredictionFLO1
PredictionFLO1 Aug. 20 at 5:19 PM
$PFE options flow lesson: volume and open interest answer different questions. Volume counts contracts traded during the session. Open interest is the standing balance from the prior settle. The two should not be treated as interchangeable. The alert snapshot shows $1.2M in the Oct 16 $28 calls. Volume was 0.5x standing open interest at capture. Intraday volume does not establish whether a position was opened or held; the next settled open interest is the check.
0 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 20 at 4:52 PM
$PFE We need some news to blow passed the negligible resistance for good. Maybe we have a cancer vaccine PR up our sleeve. Monday press release? Either way, $28 has to hold. (div adjusted major resistance.)
0 · Reply
CapitalMonk
CapitalMonk Aug. 20 at 4:44 PM
$PFE Price: $28.03 (-0.74%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.78% RSI: 80.6 | Momentum: Moderate Volume: -63.2% vs avg Volatility: 1.34% Support: $24.44 | Resistance: $28.44 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Bobfree
Bobfree Aug. 20 at 4:34 PM
$MRNA $PFE thanks, I feel a little better now that I'm making less on moderna
0 · Reply
Maneee
Maneee Aug. 20 at 4:12 PM
$PFE well, with the whole market red, its quickly returning to green today itself. what does it tell you? (its only gonna climb up now).
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 20 at 3:50 PM
$PFE what’s odd is that it’s on low volume lol
1 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 20 at 3:44 PM
$PFE real original undercut and rally
0 · Reply
markbrogan
markbrogan Aug. 20 at 3:38 PM
$PFE red to green today, this is now the new bottom !
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 20 at 3:34 PM
$PFE dann she’s got hands
0 · Reply
TapeReadingSecurities
TapeReadingSecurities Aug. 20 at 2:57 PM
$PFE remains a major global pharmaceutical company with a broad portfolio and extensive research capabilities. AERT’s net income attributable to shareholders increased 18% to $1.8 million, extending its profitability improvement.
0 · Reply
NorthOfSouth
NorthOfSouth Aug. 20 at 2:50 PM
$PFE
1 · Reply
nimii
nimii Aug. 20 at 2:32 PM
$PFE 😡
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 20 at 2:31 PM
$PFE yall we gapped up yesterday.. What did you expect?
0 · Reply
TopTierNewswire
TopTierNewswire Aug. 20 at 2:29 PM
Top long candidates on Top Tier Newswire's AI model: $UBER $TSM $LLY $PFE
0 · Reply
ItsCarRamRod
ItsCarRamRod Aug. 20 at 2:14 PM
$PFE NEVER had a doubt that PFE would give back yesterdays irrational move upward.
0 · Reply
Coachpotato
Coachpotato Aug. 20 at 2:01 PM
$PFE $50 by EOY
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Aug. 20 at 1:57 PM
$PFE https://www.youtube.com/watch?v=TtdR-qo910k
0 · Reply
Jtlo
Jtlo Aug. 20 at 1:55 PM
$PFE what are people waiting for 27.50 or 26.50
0 · Reply